Physician profile
Aakar Thaker
NPI 1215391016
$636.96
in general payments reported to CMS, 2019-2025
10 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $32.51 · 2021: $33.65 · 2022: $16.44 · 2024: $21.39 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $162.09 | 2024-2025 | |
| Pfizer INC. | $144.60 | 2019 | |
| Novo Nordisk INC | $124.17 | 2019 | |
| Amarin Pharma, INC. | $81.47 | 2019 | |
| Viiv Healthcare Company | $54.33 | 2020-2021 | |
| Fidia Pharma USA INC. | $17.57 | 2025 | Triluron, Hymovis |
| Janssen Biotech, INC. | $16.44 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.16 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.83 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aakar Thaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.